Bullish
$OCGN they have cash on hand, neocart sale coming soon and already have partnership to offset operating costs. And throw in buy back program... To me this looks better than 90% of biotechs that trade much higher. Jmo feeling much better about our position. Gl to all!
  • 8
  • 1